Eris Lifesciences (BOM:540596) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:540596 Eris Lifesciences Ltd BOM:540596
93 GF Score
Price ₹1,383.15
GF Value ₹1,645.14
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Eris Lifesciences Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BOM:540596
93GF Score
Eris Lifesciences Ltd BOM:540596
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Eris Lifesciences (BOM:540596) Overvalued in 2026?

Based on GuruFocus' analysis, Eris Lifesciences stock appears to be undervalued. The current stock price of ₹1,383.15 is trading 15.9% below its estimated GF Value™ of ₹1,645.14. GuruFocus considers Eris Lifesciences to be Modestly Undervalued.

Key valuation signals for BOM:540596:

  • Short Ratio:
  • GF Value™: ₹1,645.14 vs. price of ₹1,383.15 (15.9% below fair value)
  • GF Score™: 93/100 with 6 warning signs

No single metric tells the full story. See the BOM:540596 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eris Lifesciences Business Description

Other Exchanges ERIS:India
Address Ramdas Road, Plot No. 142/2, Shivarth Ambit, Off SBR, Near Swati Bungalows, Bodakdev, Ahmedabad, GJ, IND, 380054
Eris Lifesciences Ltd is an India-based company engaged in the manufacturing and sale of branded pharmaceutical formulations. It focuses on Lifestyle therapies such as Diabetes Care, Cardiac Care, Nutrition, Central Nervous System, and others. The company operates in a single segment that is pharmaceuticals. Some of its brands include Glimisave, Cyblex, Eritel, Atorsave and Crevast. The company works basically within India and International with the majority of revenue from India.
93GF Score

Get the complete analysis for BOM:540596

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,383.15
Price
₹1,645.14
GF Value